Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia.
D000293:Adolescent; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D002116:Calcitonin / Q000494:pharmacology* / Q000627:therapeutic use*; D002118:Calcium / Q000378:metabolism* / Q000652:urine; D002986:Clinical Trials as Topic; D003094:Collagen / Q000378:metabolism; D003404:Creatinine / Q000652:urine; D005260:Female; D005357:Fibrous Dysplasia of Bone / Q000378:metabolism*; D006801:Humans; D006909:Hydroxyproline / Q000652:urine*; D006996:Hypocalcemia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000378:metabolism*; D010758:Phosphorus / Q000378:metabolism* / Q000652:urine; D011188:Potassium / Q000378:metabolism* / Q000652:urine; D012964:Sodium / Q000378:metabolism* / Q000652:urine
D010758:Phosphorus; D002116:Calcitonin; D003094:Collagen; D012964:Sodium; D003404:Creatinine; D000469:Alkaline Phosphatase; D006909:Hydroxyproline; D011188:Potassium; D002118:Calcium